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This paper reports the complete coding sequence for a proliprotein signal peptidase (SP-ase) of
Streptococcus suis, Lsp. This is believed to be the first SP-ase described for S. suis. SP-ase II is
involved in the removal of the signal peptide from glyceride-modified prolipoproteins. By using
in vitro transcription/translation systems, it was shown that the lsp gene was transcribed in vitro.
Functionality of Lsp in Escherichia coli was demonstrated by using an in vitro globomycin resistance
assay, to show that expression of Lsp in E. coli increased the globomycin resistance. An isogenic
mutant of S. suis serotype 2 unable to produce Lsp was constructed and shown to process
lipoproteins incorrectly, including an S. suis homologue of the pneumococcal PsaA lipoprotein. Five
piglets were inoculated with a mixture of both strains in an experimental infection, to determine the
virulence of the mutant strain relative to that of the wild-type strain in a competitive challenge
experiment. The data showed that both strains were equally virulent, indicating that the knockout
mutant of lsp is not attenuated in vivo.
INTRODUCTION
Streptococcus suis is a Gram-positive organism that is an
important cause of meningitis, arthritis and septicaemia in
piglets. Piglets often do not survive the disease (Clifton-
Hadley, 1983; Vecht et al., 1985). Sows are symptomless
carriers of S. suis on their tonsils and pass the bacteria on
to their piglets, which are sensitive to the infection. Occa-
sionally, humans get infected by S. suis (Arends & Zanen,
1988). Control of the disease is hampered by the lack of
effective vaccines and sufficient, sensitive diagnostic tools.
PCR assays have been developed for the detection of
serotypes 1, 2, 7 and 9 (Smith et al., 1999b; Wisselink et al.,
1999, 2002). For other serotypes no sensitive diagnostics are
available yet. For development of vaccines and diagnostics,
more insight into the process of pathogenesis will be very
helpful. Virulence factors of S. suis are attractive vaccine
candidates and can potentially be used as tools for detec-
tion of virulent serotypes of S. suis. Recently, an in vivo
expression system was used to identify environmentally
regulated promoters under different selection conditions
(Smith et al., 2001). With this system, 36 environmentally
regulated genes were identified.
One of these genes, ivs-23/iri-24 (Smith et al., 2001) showed
similarity in the database to the regulatory genes cpsY of
Streptococcus agalactiae (Koskiniemi et al., 1998) and oxyR
of Escherichia coli (Demple, 1999). In S. agalactiae, a putative
regulatory function on capsule expression was attributed
to cpsY (Koskiniemi et al., 1998). Because, in S. suis, ivs-23/
iri-24 is not linked to the capsule operon (Smith et al., 1999a),
we here determined the gene sequences flanking ivs-23/
iri-24 in S. suis. In this paper we describe a putative operon
expressing the transcriptional regulator and show that the
operon contains a prolipoprotein signal peptidase. This type
II signal peptidase of S. suis (lsp) was cloned and charac-
terized. Functionality of Lsp was demonstrated in E. coli. An
insertional knockout mutant of lsp was constructed and the
role of the prolipoprotein signal peptidase in the patho-
genesis of S. suis was studied by comparing wild-type
and mutant strains in an experimental infection in piglets.
The data show that the lsp mutant is not attenuated in vivo.
The GenBank accession number for the sequence of lsp reported in
this paper is AF303229.
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METHODS
Bacterial strains and culture conditions. The bacterial strains
and plasmids used in this study are listed in Table 1. S. suis strains
were grown in Todd–Hewitt broth (code CM 189; Oxoid) and
plated on Columbia blood base agar plates (code CM 331; Oxoid),
containing 6 % (v/v) horse blood. E. coli strains were grown in
Luria broth (Miller, 1972) and plated on Luria broth containing
1?5 % (w/v) agar. If required, antibiotics were added in the follow-
ing concentrations: chloramphenicol (Roche), 3?4 mg ml21 for S.
suis and 10 mg ml21 for E. coli; and ampicillin (Roche), 100 mg ml21
for E. coli.
In vitro transcription/translation assay. This assay was per-
formed using the Prokaryotic DNA-Directed Translation Kit
(Amersham Life Science) according to the manufacturer’s instruc-
tions. TRAN35S-LABEL (containing 70 % L-[35S]methionine) (43?5
GBq mmol21; ICN Biomedicals) was used to label de novo-syn-
thesized proteins. After the in vitro transcription/translation, SDS-
PAGE was performed with the NuPAGE system according to the
manufacturer’s instructions. Proteins were separated on a 4–12 %
gradient gel in NuPAGE MES buffer. The gel was dried under
vacuum and the signal was detected using a phosphor-imager
(STORM, Molecular Dynamics).
Globomycin resistance assay. Stationary-phase E. coli cells were
diluted 1 : 50 in Luria broth containing appropriate antibiotics and
grown at 37 ˚C for 8 h. Ten microlitres of exponential-phase E. coli
culture was used to inoculate 100 ml Luria broth containing various
concentrations of globomycin (a generous gift of Dr Shunichi
Miyakoshi, Sankyo Co. Ltd, Tokyo, Japan). The globomycin
concentrations tested were 0, 10, 20, 40, 80, 160 and 320 mg ml21.
The cells were allowed to grow for 16 h, and the OD630 was
measured in a spectrophotometer.
DNA manipulations and sequence analysis. Routine DNA mani-
pulations were performed as described by Sambrook et al., 1989. DNA
sequences were determined on a 373A DNA Sequencing System
(Applied Biosystems). Samples were prepared by use of an ABI Prism
dye terminator cycle sequencing ready reaction kit (Applied Biosystems).
Sequencing data were assembled and analysed using the Lasergene pro-
gram (DNASTAR). The BLAST software tool (Altschul et al., 1997) was
used to search for protein sequences homologous to the deduced amino
acid sequences in the GenBank/EMBL databases using the National
Center for Biotechnology Information server (http://www.ncbi.nlm.nih.
gov/BLAST/), typically using the tBlastN option with sequence filtering
switched off and the maximum Expect value set at 0?001. Profile scan-
ning for significant matches to database motifs was performed using
the on-line ISREC ProfileScan Server (http://hits.isb-sib.ch/cgi-bin/hits_
motifscan).
Southern blotting and hybridization. Chromosomal DNA was
isolated as described by Sambrook et al. (1989). After digestion with
restriction enzymes, DNA fragments were separated on 0?8 % (w/v)
agarose gels and transferred to GeneScreen Plus hybridization
transfer membrane (NEN Life Science Products) as described by
Sambrook et al. (1989). DNA probes for the lsp and chloram-
phenicol resistance genes were labelled with [a-32P]dCTP (111 GBq
mmol21; Amersham Life Science) by use of a random-primed DNA
labelling kit (Boehringer). The DNA on the blots was pre-hybridized
at 65 ˚C for at least 30 min and subsequently hybridized at 65 C˚ for
16 h with the appropriate DNA probes in a buffer containing 0?5 M
sodium phosphate, pH 7?2, 1 mM EDTA and 7 % SDS. After hybri-
dization, the membranes were washed twice with a buffer containing
Table 1. Bacterial strains and plasmids
Strain/plasmid Relevant characteristics* Source/reference
E. coli
XL-1 Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1
lac [F9 (proAB lacIqZ)M15] Tn10 (TetR)
Stratagene
S. suis
10 Virulent serotype 2 strain Vecht et al. (1989)
10DLsp Isogenic lsp mutant of strain 10 This work
Plasmids
pGEM7Zf(+) Replication functions of pUC, AmpR Promega
pKUN19 Replication functions of pUC, AmpR Konings et al. (1987)
pMR11 pKUN19 containing S. suis mrp gene Smith et al. (1992)
pC194 CmR Horinouchi & Weisblum (1982b)
pUK21 Replication functions of pUC Laboratory collection
pUK21-Cm pUK21 with a 900 bp EcoRI–HindIII fragment containing CmR
preceded by the MRP promoter inserted in HindIII site
Laboratory collection
pE194 EmR Horinouchi & Weisblum (1982a)
pIVS-E Replication functions of pWVO1, SpcR,
promoterless erm gene of pE194
Smith et al. (2001)
pIVS-23 pIVS-E containing a 850 bp insert showing homology to
S. agalactiae CpsY and to E. coli OxyR
Smith et al. (2001)
pLSP-2 pGEM7Zf(+) containing 3 kb DraI–ClaI fragment of lsp This work
pLSP-3 pLSP-2 in which a Cm resistance cassette preceded by the
MRP-promoter was inserted into the unique StuI site
This work
*TetR tetracycline resistance; AmpR ampicillin resistance; CmR chloramphenicol resistance; EmR erythromycin resistance.
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40 mM sodium phosphate, pH 7?2, 1 mM EDTA and 5 % SDS at
65 C˚ for 30 min and twice with a buffer containing 40 mM sodium
phosphate, pH 7?2, 1 mM EDTA and 1 % SDS at 65 ˚C for 30 min.
The signal was detected using a phosphor-imager (Storm, Molecular
Dynamics).
Construction of a lsp knockout mutant. To construct the
mutant strain 10DLsp, the pathogenic strain 10 (Vecht et al., 1989,
1992) of S. suis serotype 2 was electrotransformed (Smith et al.,
1995) with the plasmid pLSP-3 (Fig. 1). In this plasmid the lsp gene
was inactivated by the insertion of a resistance cassette, consisting of
the chloramphenicol resistance gene from pC194 (Horinouchi &
Weisblum, 1982b), preceded by the promoter region of the mrp
gene (Smith et al., 1992). To create pLSP-3, pLSP2 (Fig. 1) was
digested with StuI, and ligated to the 900 bp SmaI–EcoRV fragment
from pUK21-Cm containing the chloramphenicol resistance cassette
preceded by the promoter region of the mrp gene. The ligation
mixture was transformated to E. coli XL-1blue cells, and ampicillin-
and chloramphenicol-resistant colonies were selected on Luria broth
containing 1?5 % (w/v) agar, 100 mg ampicillin ml21 and 10 mg
chloramphenicol ml21. After electrotransformation of strain 10
with pLSP-3, chloramphenicol-resistant colonies were selected on
Columbia blood base agar plates containing 3?4 mg chloramphenicol
ml21. Southern blotting and hybridization experiments were used to
screen for double-crossover integration events (data not shown).
Phenotypic characterization of the lsp knockout mutant.
S. suis strains S10 and 10DLsp were grown in the presence and
absence of [U-14C]palmitate (Amersham Bioscience) to allow radio-
labelling of lipoproteins. Overnight cultures of S. suis S10 and
10DLsp were diluted 1 : 20 into 5 ml pre-warmed Todd–Hewitt
broth in triplicate. They were incubated at 37 ˚C for 1–2 h (early
exponential phase), before the addition of either [14C]palmitate
(25 mCi [925 kBq] in 137 ml ethanol) or ethanol (137 ml) as controls.
Control broths were used to monitor growth (OD595) until late-
exponential phase. Cells from the cultures containing radiolabel
were harvested by microcentrifugation (13 000 g for 5 min), resus-
pended in 1 ml sterile phosphate-buffered saline and recentrifuged.
This was repeated three times and the washed cells were then pre-
pared for SDS-PAGE analysis as described previously (Hamilton
et al., 2000). After drying, the gels were exposed to Kodak BIOMAX
MR2 film (Anachem) at 280 ˚C for about 14 days. Autoradiograms
were developed using Kodak GBX developer and fixer (Sigma)
according to the manufacturer’s instructions.
Western blotting following SDS-PAGE was performed as described
previously (Hamilton et al., 2000) using a rabbit polyclonal antiserum
raised against the PsaA putative lipoprotein of Streptococcus pneumo-
niae (kindly supplied by Dr Jacquelyn Sampson, National Center for
Infectious Diseases, Atlanta, GA, USA). This antiserum cross-reacts
with PsaA and other lipoproteins in the streptococcal LraI family
(Harrington et al., 2000). BLAST searches of the draft S. suis genome,
which has been made available by the Sanger Centre (http://
www.sanger.ac.uk/Projects/S_suis/) suggested the presence of a PsaA
homologue (LraI family member) in S. suis and that this sequence
includes a signal peptide matching the consensus for proven Gram-
positive bacterial lipoproteins (Sutcliffe & Harrington, 2002).
Experimental infections. Germfree piglets, crossbreeds of Great
Yorkshire and Dutch Landrace, were obtained from sows by caesar-
ean sections. The surgery was performed in sterile flexible film iso-
lators. Piglets were allotted to groups of 5, and were housed in
sterile stainless steel incubators. Housing conditions and feeding
regimens were as described before (Vecht et al., 1989, 1992). Six-
day-old piglets were inoculated intranasally with about 107 c.f.u. of
Bordetella bronchiseptica 92932, to predispose them to infection with
S. suis. Two days later the piglets were inoculated intranasally with
106 c.f.u. of S. suis strain 10 plus 106 c.f.u. of S. suis strain 10DLsp.
To determine differences in virulence between wild-type and mutant
strains, LD50 values should be determined. To do this, large numbers
of piglets are required, which for ethical reasons is not acceptable.
To circumvent this problem, we performed co-colonization studies.
To monitor for the presence of S. suis and B. bronchiseptica and to
check for absence of contaminants, swabs taken from the naso-
pharynx and the faeces were cultured three times a week. The swabs were
plated directly onto Columbia agar containing 6 % horse blood, or
grown for 48 h in Todd–Hewitt broth and subsequently again plated
onto Columbia agar containing 6 % horse blood. Piglets were moni-
tored twice a day for clinical signs and symptoms, such as fever, ner-
vous signs and lameness. Blood samples from each piglet were
collected three times a week. Leukocytes were counted with a cell
counter. The piglets were killed when specific signs of an S. suis
infection were observed, such as arthritis or meningitis, or when
they became mortally ill. The other piglets were killed 2 weeks after
inoculation with S. suis. All piglets were examined for pathological
changes. Tissue specimens from heart, lung, liver, kidney, spleen and
tonsil, and from the organs specifically involved in an S. suis infec-
tion (central nervous system, serosae and joints), were sliced with a
scalpel or a tissuemiser. Tissue slices from each organ or site were
resuspended in 2–25 ml Todd–Hewitt broth containing 15 % (v/v)
glycerol, depending on the size of the tissue slice. The suspension
was centrifuged at 3000 r.p.m. for 5 min. The supernatant was col-
lected and serial dilutions were plated on Columbia agar containing
6 % horse blood, as well as on Columbia agar plates containing 6 %
horse blood and 3?4 mg chloramphenicol ml21 to quantitate the
number of wild-type and mutant bacteria present. The number of
mutant strain 10DLsp cells was determined by counting the number
of c.f.u. on the appropriate serial dilution on the selective plates; the
number of wild-type strain 10 cells was determined by counting the
number of c.f.u. on the appropriate serial dilution on the Columbia
agar blood plates, from which the number of c.f.u. counted on the
selective plates was subtracted. When both wild-type and mutant
bacteria were found in tissues, the ratio of wild-type and mutant
Fig. 1. Schematic representation of pLSP-2 and pLSP-3. A
3 kb ClaI–DraI fragment that hybridized with probe ivs-23/iri-24
was cloned into pGEM7Zf(+) digested with ClaI and SmaI,
yielding pLSP-2. To create pLSP-3, the 900 bp SmaI–EcoRV
fragment of pUK21-Cm, containing the chloramphenicol resis-
tance gene from pC194 (Horinouchi & Weisblum, 1982b), pre-
ceded by the promoter region of the mrp gene (Smith et al.,
1992), was inserted in the StuI site of lsp.
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strain was determined more precisely, by toothpicking about 100
individual colonies onto both Columbia blood base agar plates
and Columbia blood base agar plates containing 3?4 mg chloram-
phenicol ml21.
All animal experiments were approved by the ethical committee of the
Institute for Animal Science and Health in accordance with the Dutch
law on animal experiments.
RESULTS
lsp is located in a putative operon
One of the clones selected from a genomic library of S. suis
serotype 2 was induced both in vivo and under iron-
restricted conditions. This clone, ivs-23/iri-24, showed
similarity in the database to the 59 part of cpsY of
Streptococcus agalactiae, and to oxyR of E. coli (Smith
et al., 2001). A 32P-labelled probe of ivs-23/iri-24 was used to
identify the flanking regions from chromosomal DNA of
S. suis strain 10. A 3 kb ClaI–DraI fragment was detected
and cloned into pGEM7Zf(+), yielding pLSP-2 (Fig. 1).
The complete sequence of the insert was determined.
Examination of the sequence revealed the presence of
three complete and partially overlapping ORFs, and two
incomplete ORFs (Fig. 1). The two incomplete ORFs are
located at the 59 and 39 ends of the sequence and showed
similarity in the database to genes encoding a regulatory
protein for C-P lyase of Streptomyces griseus and to a gene
encoding PHNA protein of E. coli respectively. 59 of the first
complete ORF, a putative 235 and 210 promoter sequence
was found. Upstream of each start codon putative RBSs were
found. 39 of the third complete ORF, putative 235 and 210
promoter sequences were found. Together these data
suggest that the three ORFs are transcribed as an operon
and that the incomplete ORFs at the 39 and 59 end of
the sequence do not belong to this operon.
The first ORF of the putative operon encoded a 304 amino
acid protein that was highly similar (219/300 [73 %] amino
acid identity) to Streptococcus pneumoniae SP0927, a
putative transcriptional regulator of the LysR family,
along with similarities to other regulators such as CpsY
and OxyR (as described above). Sequence analysis con-
firmed that this translated sequence matched the database
motifs for both the LysR family helix–turn–helix (Pfam
PF00126) and substrate binding (Pfam PF03466) domains.
The second ORF of the putative operon encoded a 154
amino acid protein that was highly similar (91/152 [59 %]
amino acid identity) to Streptococcus agalactiae SAG1366
and to Streptococcus pneumoniae SP0928 (78/144 [54 %]
amino acid identity), both of which are annotated as puta-
tive prolipoprotein signal peptidases (Lsp; type II signal
peptidase). Sequence analysis confirmed that this translated
sequence matched the database motif for the signal pepti-
dase II family (Pfam PF01252). Finally, the last ORF of
the putative operon encoded a 297 amino acid protein that
was highly similar (254/297 [85 %] amino acid identity) to
Streptococcus pneumoniae SP0929, a putative ribosomal
pseudouridine synthase. Sequence analysis confirmed that
this translated sequence matched the database motifs for
both an S4 domain (Pfam PF01479), which probably medi-
ates binding to RNA, and the RluD pseudouridine synthase
family (Pfam PF00849; PDOC00869). Pseudouridine syn-
thases modify RNA base composition by converting uracil
bases to pseudouridine (Conrad et al., 1998). Inspection of
the published microbial genomes and the publicly available
unpublished genomes for Streptococcus gordonii and
Streptococcus mitis indicated that this putative three-ORF
operon is well conserved within the streptococcal genomes
(e.g. the SP0927–SP0929 locus: Tettelin et al., 2001).
Moreover, chromosomal loci encoding putative Lsp and
putative pseudouridine synthase enzymes are apparently
uniformly present in the genomes of Gram-positive bacteria
(e.g. LL0997 and LL0998 in the genome of Lactococcus lactis:
Bolotin et al., 2001) although this gene arrangement is not
conserved in other taxa such as the Proteobacteria. The
upstream presence of the putative LysR family member
is not conserved in the non-streptococcal Gram-positive
bacterial genomes and a variety of genes may be found
preceding lsp (e.g. L. lactis LL0996 encodes a putative
lumazine synthase). In this respect it is noted that in all the
available streptococcal genomes there is sequence overlap
between the ORFs encoding the putative Lsp and the
pseudouridine synthase, whereas the overlap between lysR
and lsp is not fully conserved.
Sequence analysis of Lsp of S. suis
A hydrophobicity plot (Kyte–Doolittle) and various tools
for the prediction of membrane-spanning domains revealed
the presence of four hydrophobic regions (data not shown),
suggesting a similar membrane localization for S. suis Lsp as
described for other Lsp enzymes (Witke & Go¨tz, 1995;
Pra´gai et al., 1997; Tjalsma et al., 1999b). The protein
sequence of S. suis Lsp was compared to the sequences of
other characterized signal peptidase II enzymes, notably that
of Bacillus subtilis, wherein five conserved domains forming
a potential active site have recently been identified (Zhao &
Wu, 1992; Sankaran & Wu, 1994a; Witke & Go¨tz, 1995;
Pra´gai et al., 1997; Tjalsma et al., 1999b). This analysis
confirmed that the strictly conserved N-terminal Domain I
aspartic acid (D14 in the B. subtilis sequence) which is
necessary for enzyme stability and function (Sankaran &
Wu, 1994b; Tjalsma et al., 1999b) is conserved in the Lsp
sequence. The other five critical residues identified by
Tjalsma et al. (1999b) are located in the two motifs NXXD
(Domain III) and FNXAD (Domain V), wherein the two
aspartates are proposed to form a catalytic dyad in the
protease active site. All five of the critical residues identified
in these two motifs are fully conserved in the S. suis Lsp
sequence.
Lsp is expressed in vitro
Expression of Lsp was determined by using an E. coli-based
in vitro transcription/translation system on pLSP-2.
pGEM7Zf(+) was used as a negative control. Three
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proteins were expressed that corresponded very well to the
predicted sizes of the S. suis LysR family protein, the putative
pseudouridine synthase and Lsp (respectively 34?7, 32?8
and 17?5 kDa) (data not shown). The negative control
pGEM7Zf(+) expressed the a-LacZ fragment as well as
b-lactamase (Amp) (data not shown). These data clearly
showed that all three genes were expressed very efficiently
from pLSP-2.
Globomycin resistance
To test whether Lsp was functional in E. coli, we used a
globomycin sensitivity assay. Globomycin is a cyclic peptide
antibiotic that specifically inhibits the processing of pro-
lipoprotein to mature lipoprotein (Inukai et al., 1978).
Gram-negative organisms, like E. coli, are especially sensitive
to this antibiotic due to inhibition of the murein lipoprotein
processing. Overexpression of cloned signal peptidase genes
from both Gram-negative and Gram-positive bacteria was
shown to cause globomycin resistance in E. coli (Tokunaga
et al., 1983; Zhao & Wu, 1992; Witke & Go¨tz, 1995). This
globomycin resistance is generally used to demonstrate
functionality of lipoprotein signal peptidases. pLSP-2 was
used for the expression of Lsp. In pLSP-3, a chloram-
phenicol resistance cassette was inserted into the lsp gene to
inactivate the gene. This construct was used as a negative
control. As a second negative control, pGEM7Zf(+)
without insert was included in the assay. E. coli cultures
containing either one of the plasmids were grown overnight
in media containing various concentrations of globomycin.
After 16 h of growth the OD630 of the cultures was mea-
sured. Fig. 2 shows that E. coli harbouring pGEM7Zf(+) or
pLSP-3 did not grow in the presence of a concentration of
globomycin higher than 20–40 mg ml21. In contrast, E. coli
harbouring pLSP-2 could grow in the presence of a
concentration of globomycin of at least 320 mg ml21
(Fig. 2), although the maximum optical density measured
for this strain was lower than for the other strains. This
indicates that the expression of Lsp and/or either of the
other proteins encoded on pLSP-2 slightly inhibited the
growth of E. coli. The increase of globomycin resistance due
to expression of Lsp demonstrates that lsp indeed encodes a
signal peptidase II that is functional in E. coli.
Role of Lsp in pathogenesis of S. suis serotype 2
To test the role of Lsp in the pathogenesis of S. suis, an
isogenic knockout mutant of Lsp was constructed in strain
10, yielding strain 10DLsp. Strain 10DLsp was constructed
by electroporation of pLSP-3, in which the lsp gene was
inactivated by insertion of a chloramphenicol resistance
cassette, into S. suis (Fig. 1) (Smith et al., 1995). Southern
blotting and hybridization experiments were used to dis-
criminate isolates in which double-crossover events had
occurred from those in which single-crossover events had
occurred (data not shown). To characterize the mutant
phenotype, the strain 10 parent and strain 10DLsp were
grown in the presence of radiolabelled palmitic acid, and
radiolabelled lipoproteins were visualized after SDS-PAGE
and autoradiography (Fig. 3). The signal peptide processing
Fig. 2. Globomycin resistance assay. OD630 of E. coli cultures
harbouring different plasmids was measured after 16 h of
growth. Black bars, pLSP-2; white bars, pGEM7Zf(+); hatched
bars, pLSP-3. Bars represent the means of triplicate experi-
ments; error bars indicate the standard error of the mean (SEM).
Fig. 3. Radiolabelling of S. suis lipoproteins with [U-14C]palmitic
acid. S. suis strains S10 and 10DLsp were grown in the pre-
sence of [U-14C]palmitate and the labelled proteins were ana-
lysed by SDS-PAGE and autoradiography. Lane 1, S. suis
strain S10; lane 2, S. suis strain 10DLsp. Positions of the
molecular mass standards in kDa are marked on the left. Some
of the radiolalled bands shifted to higher molecular masses
(consistent with the accumulation of prolipoproteins with
uncleaved signal peptides) are indicated on the right ($).
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of at least four radiolabelled proteins was affected in strain
10DLsp, as indicated by a shift of the radiolabelled protein
band to a higher molecular mass, which is consistent with
the accumulation of the prolipoprotein form (Fig. 3, lane 2).
However, the appearance of doublets (prolipoprotein and
putative ‘mature-like’ forms) suggested that some alter-
native path of lipoprotein processing was also active in the
case of some lipoproteins. To verify the mutant phenotype
further, Western blot analysis was performed using a poly-
clonal antibody to the pneumococcal PsaA lipoprotein.
Consistent with the bioinformatic detection of a pneumo-
coccal PsaA homologue (LraI family lipoprotein) in S. suis
(see Methods), a cross-reacting band of about 35 kDa was
detected in strain 10, whereas this band was shifted to a
position consistent with the accumulation of the prolipo-
protein in strain 10DLsp (Fig. 4). Cumulatively, these data
confirmed that lipoprotein processing is disrupted in strain
10DLsp.
Because we were unable to determine LD50 values for the
mutant in pigs for ethical reasons, it was decided to do a
competitive co-colonization experiment with the wild-type
strain. The virulence of strain 10DLsp was compared to that
of the wild-type in an experimental infection in piglets. The
mutant strain 10DLsp was mixed with wild-type bacteria in
competition challenge experiments to determine the relative
attenuation of the mutant strain. Using in vitro conditions,
the growth rates of wild-type and mutant strain in Todd–
Hewitt medium were found to be essentially identical (data
not shown). Wild-type and mutant bacteria were inoculated
at an actual ratio of 4 : 1 (1?56106 c.f.u. of strain 10 and
46105 c.f.u. of strain 10DLsp), in five piglets (nos 1, 26, 42,
44 and 49). During the experiment, piglets that developed
specific S. suis symptoms (meningitis, arthritis or mortal
illness) were killed. Piglets that did not develop these
symptoms were killed at the end of the experiment. Three
out of five piglets developed central nervous signs (nos 26,
42 and 44); one of them also developed a severe pericarditis
(no. 44). Piglet no. 49 developed a severe arthritis in one leg.
Piglet no. 1 survived until the end of the experiment, but
at the post-mortem section a peritonitis and probably a
starting meningitis was observed. As shown in Fig. 5(a),
wild-type and mutant bacteria were re-isolated from tonsils
in a ratio of about 14 : 1 (wild-type : mutant), while the input
ratio was 4 : 1. This indicated that the mutant bacteria
colonized the tonsil less efficiently than the wild-type
bacteria. Fig. 5(b) shows that no large differences were
found in the ratio of re-isolated wild-type bacteria and
mutant bacteria, nor in the number of organs that were
colonized by wild-type or mutant bacteria. Taken together,
these data indicate that, although the mutant seemed to
colonize the tonsil slightly less efficient that the wild-type
strain, the mutant strain 10DLsp is as virulent as the wild-
type strain.
DISCUSSION
In this paper we describe the identification and character-
ization of Lsp, a lipoprotein signal peptidase of S. suis
serotype 2. The lsp gene was found to be part of a putative
operon containing three overlapping genes. These genes
were preceded by a putative promoter sequence. Down-
stream of the third gene was another putative promoter
sequence. These findings suggest that this putative operon
1 2 3
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37
25
Fig. 4. Western blot analysis of the putative S. suis homologue
of pneumococcal PsaA. Cell extracts of S. suis strains S10
and 10DLsp were analysed by SDS-PAGE and Western blot-
ting using a polyclonal anti-PsaA antibody. Lane 1, Bio-Rad
prestained standards with molecular masses in kDa marked on
the left. Lane 2, S. suis strain S10. Lane 3, S. suis strain
10DLsp. The shifting to a higher molecular mass of the cross-
reacting band in lane 3 is consistent with the accumulation of
a prolipoprotein with an uncleaved signal peptide.
(a) (b)
Fig. 5. Efficacy of colonization of wild-type and mutant bacteria
on various organs of infected pigs. (a) Colonization of wild-type
strain 10 and mutant strain 10DLsp on the tonsils: X, piglet
no. 1; %, piglet no. 26; m, tonsil piglet no. 42; n, tonsil piglet
no. 44; &, tonsil piglet no. 49. (b) Colonization of the specific
organs (CNS, central nervous system): m, CNS piglet no. 1;
&, joints piglet no. 1; $, peritoneum piglet no. 1; %, spleen piglet
no. 26; n, CNS piglet no. 26; _, kidney piglet no. 42; X, CNS
piglet no. 42; 6, joints piglet no. 42; +, CNS piglet no. 44;
V, joints piglet no. 44; #, pericardium piglet no. 44; ,, spleen
piglet no. 49; ., heart piglet no. 49; e, joint piglet no. 49. Each
symbol represents the numbers of wild-type or mutant bacteria
isolated from one particular organ, from one pig.
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contains only the three overlapping genes. Besides lsp, this
putative operon contained a gene encoding a protein that is
predicted to belong to the LysR family of transcriptional
regulators and a gene encoding a putative pseudouridine
synthase. This chromosomal locus was noted to be con-
served in other streptococcal genomes, whilst the associa-
tion of the lsp gene with that for a putative pseudouridine
synthase is conserved in Gram-positive bacterial genomes
generally. The LysR family transcriptional regulator was
identified with an IVET system as being environmentally
regulated (Smith et al., 2001). Two different conditions were
used to select environmentally regulated promoters: iron-
restricted conditions and in vivo conditions. With both
selections, the regulator gene was found. It is generally
accepted that environmentally regulated genes, especially in
vivo-induced genes, are potential virulence factors (Mahan
et al., 1993). For this reason we studied the role of the
predicted Lsp enzyme encoded by the gene adjacent to the
regulator in the pathogenesis of S. suis serotype 2.
Lsp is involved in the removal of the signal peptide from
diacylglyceride-modified prolipoproteins (Sankaran & Wu,
1994a, b). In Gram-negative organisms several enzymes
involved in the lipid-modification of prolipoproteins,
including Lsp, are essential for normal growth, cell division
and viability (Sankaran & Wu, 1994a, b; Gan et al., 1993;
Gupta et al., 1993; Williams et al., 1989; Yamagata et al.,
1982). In contrast, lsp of the Gram-positive organism
B. subtilis is not necessary for growth and viability, even
though the PrsA lipoprotein is an essential maturase enzyme
(Tjalsma et al., 1999a). Moreover, in S. pneumoniae, one of
the enzymes involved in lipid-modification, prolipoprotein
diacylglyceryl transferase (encoded by lgt), is not essential
for cell growth in vitro, but is essential for viability during
infection (Petit et al., 2001). In Gram-positive organisms
several roles have been attributed to lipoproteins such as
participation in antibiotic resistance, ABC transporter
systems, adhesion, protein export and extracytoplasmic
folding, and sensory systems (Sutcliffe & Russell, 1995;
Sutcliffe & Harrington, 2002). The abundance of putative
lipoproteins in typical bacterial genomes (Sutcliffe &
Harrington, 2002) suggests that this class of proteins is of
considerable physiological significance. In streptococci
other than S. suis, several lipoproteins have been shown to
be involved in virulence (Burnette-Curley et al., 1995; Berry
& Paton, 1996; Kitten et al., 2000; Brown et al., 2001; Marra
et al., 2002). Moreover, mutants disrupted in lsp have been
shown to be attenuated in signature-tagged mutagenesis
studies of Staphylococcus aureus (Mei et al., 1997; Coulter
et al., 1998).
Type II signal peptidase activity of Lsp was initially
demonstrated using a globomycin assay. We showed that
overexpression of Lsp in E. coli resulted in an increased
resistance to globomycin. To study the role of Lsp in the
pathogenesis of S. suis, an isogenic knockout mutant of
lsp was constructed in a wild-type S. suis serotype 2 strain.
To construct the mutant, we used a plasmid replicating in
E. coli in which the lsp gene was inactivated by the insertion
of a chloramphenicol resistance gene (pLSP-3). In the
globomycin assay, E. coli containing pLSP-3 did not show an
increased globomycin resistance, whereas the construct
containing the intact lsp gene did. This strongly indicated
that in pLSP-3, Lsp was non-functional. To confirm the
phenotype of strain 10DLsp, lipoproteins were radiolabelled
by growth in the presence of radiolabelled [14C]palmitic acid.
Comparison with the lipoprotein profile for strain 10 indi-
cated that multiple radiolabelled bands accumulated in a
higher molecular mass form, consistent with a failure to
remove signal peptides from prolipoproteins (Fig. 3). This
observation was confirmed by Western blot analysis, which
demonstrated the accumulation in strain 10DLsp of the
prolipoprotein form of a putative LraI family member (PsaA
homologue; Fig. 4).
The virulence of the S. suis lsp mutant was tested in an
experimental infection model in piglets. Since we are unable
to determine LD50 values for the mutant strain in pigs, it was
decided to compare the virulence of strain 10DLsp to the
wild-type S. suis strain 10 in a competitive co-colonization
assay in piglets. These kinds of co-colonization experiments
have been successfully applied to determine the virulence
of mutants of Actinobacillus pleuropneumoniae in piglets
(Fuller et al., 2000). Moreover, we recently successfully used
this procedure to determine the virulence of an isogenic
knockout of a gene encoding a fibronectin- and fibrinogen-
binding protein (de Greeff et al., 2002). The data clearly
showed that the lsp mutant strain was capable of colonizing
both the tonsil and the organs specific for an S. suis infection,
as efficiently as the wild-type strain. This means that both
strains are equally virulent, and that the knockout mutant of
lsp is not attenuated in vivo. Thus this phenotype contrasts
that of other Gram-pathogens defective in enzymes
necessary for lipoprotein biosynthesis (Mei et al., 1997;
Coulter et al., 1998; Petit et al., 2001). This could suggest that
lipoproteins do not play a role in the pathogenicity of S. suis
but may also indicate that lipoproteins can be processed via
an alternative route, independently of Lsp. Our data (Fig. 4)
indicate that the PsaA homologue at least is not processed by
an alternative path but several other lipoproteins radio-
labelled with palmitic acid may be (Fig. 4). Based on
Southern blot experiments, we have no reason to assume
that a second Lsp gene is present in S. suis, and BLAST
searches of the draft S. suis genome indicate that there is only
a single copy of Lsp (i.e. the sequence reported herein). Thus
the processing of lipoproteins in strain 10DLsp may be due
to the presence of cryptic sites for other signal peptidases in
some lipoprotein signal peptides. Alternatively, it may be
that as yet undescribed pathway(s) for processing of lipo-
proteins exist in Gram-positive bacteria. This idea is
supported by the observations of Tjalsma et al. (1999a),
who showed that mature-like forms of the lipoprotein PrsA
were still found in a knockout mutant of lsp in B. subtilis.
Whilst these authors excluded the possibility of processing
by type I signal peptidases taking over the function of Lsp,
how the mature-like forms were alternatively processed
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could not be explained. Thus, based on our data, and the
information available in the literature, we hypothesize
that in S. suis alternative processing of lipoproteins can also
take place.
In conclusion, we describe the cloning and characterization
of the prolipoprotein signal peptidase of S. suis, Lsp. We also
show that an isogenic mutant of lsp is not attenuated in vivo
in piglets. Further research is necessary to determine whether
lipoproteins can be alternatively processed in S. suis.
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